Rheumatology International

, Volume 32, Issue 10, pp 3315–3317

Drug-induced lupus in anti-TNF-alpha therapy and its treatment with rituximab

  • Juan C. Diaz
  • Santiago Vallejo
  • Carlos A. Cañas
Short Communication

Abstract

We report three patients with rheumatoid arthritis (RA) who were treated with anti-TNF-α agents and who developed drug-induced lupus (DIL). Two of them received etanercept and the remainder adalimumab. We also present the favorable response observed with the withdrawal of the anti-TNF-alpha agents and the introduction of rituximab. Through this intervention, we observed a very good control of the activity of both DIL and RA without additional adverse reactions.

Keywords

Rheumatoid arthritis Etanercept Adalimumab Drug-induced lupus Rituximab 

References

  1. 1.
    Nash PT, Florin TH (2005) Tumour necrosis factor inhibitors. Med J Aust 183:205–208PubMedGoogle Scholar
  2. 2.
    Hochberg MC, Lebwohl MG, Plevy SE et al (2005) The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. Semin Arthritis Rheum 34:819–836PubMedCrossRefGoogle Scholar
  3. 3.
    Williams EL, Gadola S, Edwards CJ (2009) Anti-TNF-induced lupus. Rheumatology (Oxford) 48:716–720CrossRefGoogle Scholar
  4. 4.
    De Bandt M (2006) Lessons for lupus from tumor necrosis factor blockade. Lupus 15:762–767PubMedCrossRefGoogle Scholar
  5. 5.
    Cairns AP, Crockard AD, McConnell JR et al (2001) Reduced expression of CD44 on monocytes and neutrophils in systemic lupus ertihematosus: relations with apoptotic neutrophils and disease activity. Ann Rheum Dis 60:950–955PubMedCrossRefGoogle Scholar
  6. 6.
    Groom JR, Fletcher CA, Walters SN et al (2007) BAFF and MyD88 signals promote a lupus like disease independent of T cells. J Exp Med 204:1959–1971PubMedCrossRefGoogle Scholar
  7. 7.
    Pers JO, Daridon C, Devauchelle V et al (2005) BAFF overexpression is associated with autoantibody production in autoimmune diseases. Ann N Y Acad Sci 1050:34–39PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag 2011

Authors and Affiliations

  • Juan C. Diaz
    • 1
  • Santiago Vallejo
    • 1
  • Carlos A. Cañas
    • 2
  1. 1.Department of Internal MedicineCES UniversityCaliColombia
  2. 2.Rheumatology UnitFundación Valle del LiliCaliColombia

Personalised recommendations